SOZO® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment

Expanded indication enables clinicians to detect sarcopenia risk from the same rapid SOZO scan, supporting earlier intervention in cancer care. CARLSBAD, Calif., Aug. 18, 2026 /PRNewswire/ — ImpediMed, a leader in the development and commercialization of medical technologies to…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks